AB0444 SAFETY PROFILE OF BIOLOGICAL THERAPY IN RHEUMATOID ARTHRITIS IN MOROCCO. DATA FROM THE RBSMR
A. Kherrab(Cadi Ayyad University), R. Niamane(Hôpital Militaire Avicenne), H. Hassikou, R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), F. Allali(Délégation Paris 5), I. El Bouchti, I. Chergaoui(Cadi Ayyad University), Taoufik Harzy(Hôpital El Ayachi), Rédouane Abouqal(Mohammed V University), Ihsane Hmamouchi(International University of Rabat), A. Chbihi-Kaddouri(Cadi Ayyad University), S. Janani(SRM Institute of Science and Technology), A. Bezza, A. El Maghraoui, M. Ghazi(Cadi Ayyad University), I. Ghozlani(Régie Autonome Multi Services D'Agadir)
Cited by 1
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114